These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4095115)

  • 21. Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?
    Pisters PW; Evans DB
    Ann Surg; 2008 Aug; 248(2):152-3. PubMed ID: 18650622
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
    Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
    Merlano M; Russi EG; Numico G; Colantonio I; Garrone O; Pelissero A; Granetto C; Gasco M; Di Costanzo G; Heouaine A; Vigna Taglianti R; Cipolat M
    Radiother Oncol; 2005 May; 75(2):193-6. PubMed ID: 16086909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
    Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
    Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicities and effects of involved-field irradiation with concurrent cisplatin for unresectable carcinoma of the pancreas.
    Kawakami H; Uno T; Isobe K; Ueno N; Aruga T; Sudo K; Yamaguchi T; Saisho H; Kawata T; Ito H
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1357-62. PubMed ID: 16029793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoradiation using low-dose cisplatin and 5-fluorouracil in locally advanced squamous cell carcinoma of the skin: a report of two cases.
    Fujisawa Y; Umebayashi Y; Ichikawa E; Kawachi Y; Otsuka F
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S81-5. PubMed ID: 17052540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
    Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: a phase I-II study.
    Nori D; Merimsky O; Osian AD; Heffernan M; Cortes E; Turner JW
    J Surg Oncol; 1996 Apr; 61(4):300-5. PubMed ID: 8628003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study.
    Rossi CR; Foletto M; Mocellin S; Pilati P; De SM; Deraco M; Cavaliere F; Palatini P; Guasti F; Scalerta R; Lise M
    Cancer; 2002 Jan; 94(2):492-9. PubMed ID: 11900234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of advanced epidermoid carcinoma of the oesophagus with combined 5-fluorouracil, adriamycin and cis-platinum (FAP)].
    Gisselbrecht C; Calvo F; Mignot L; Pujade E; Bouvry M; Danne O; Belpomme D; Morvan F; Marty M
    Nouv Presse Med; 1982 May; 11(24):1859-62. PubMed ID: 6892500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New anthracyclines in the treatment of solid tumors in the advanced stage].
    Pannuti F; Martoni A; Lelli G; Camaggi CM; Strocchi E; Fruet F
    G Ital Chemioter; 1985; 32(1):49-56. PubMed ID: 3868636
    [No Abstract]   [Full Text] [Related]  

  • 36. [Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil].
    Bedenne L; Chauffert B; Lorcerie B; Faivre J; Hillon P; Klepping C; Martin F
    Gastroenterol Clin Biol; 1989 Oct; 13(10):845-6. PubMed ID: 2556316
    [No Abstract]   [Full Text] [Related]  

  • 37. Radiation therapy combined with Adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Gastrointestinal Tumor Study Group.
    Cancer; 1985 Dec; 56(11):2563-8. PubMed ID: 2864997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation therapy with and without chemotherapy in the treatment of localized unresectable pancreatic carcinoma. A retrospective analysis.
    Jones KG; Lindberg RD; Epremian B; Jose B; Spanos WJ
    J Ky Med Assoc; 1987 Jun; 85(6):305-9. PubMed ID: 3611960
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II trial of the association of doxorubicin, 5 FU and cis platinum in hormonally unresponsive metastatic carcinoma of the prostate.
    Droz JP; Fargeot P; Laplaige P; Moran-Ribon A; Piot G
    Prog Clin Biol Res; 1987; 243B():235-42. PubMed ID: 3659022
    [No Abstract]   [Full Text] [Related]  

  • 40. Survival after combined modality therapy for pancreatic cancer.
    Bruckner HW; Kalnicki S; Dalton J; Snady H; Schwartz GK; Chesser MR; Lehrer D; Mandeli J; Harpaz N; Janus C
    J Clin Gastroenterol; 1993 Apr; 16(3):199-203. PubMed ID: 8505490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.